265 related articles for article (PubMed ID: 22421948)
1. Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer.
Garrett CR; Hassabo HM; Bhadkamkar NA; Wen S; Baladandayuthapani V; Kee BK; Eng C; Hassan MM
Br J Cancer; 2012 Apr; 106(8):1374-8. PubMed ID: 22421948
[TBL] [Abstract][Full Text] [Related]
2. Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients.
Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
World J Gastroenterol; 2017 Jul; 23(28):5196-5205. PubMed ID: 28811714
[TBL] [Abstract][Full Text] [Related]
3. Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer.
Al Omari A; Abdelkhaleq H; Al-Hussaini M; Turfa R; Awad N; Hassan MM; Alfaqih MA; Garrett CR
J Glob Oncol; 2018 Jul; 4():1-10. PubMed ID: 30084749
[TBL] [Abstract][Full Text] [Related]
4. The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus.
Tarhini Z; Manceur K; Magne J; Mathonnet M; Jost J; Christou N
Sci Rep; 2022 Jul; 12(1):12374. PubMed ID: 35859114
[TBL] [Abstract][Full Text] [Related]
5. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer.
Paulus JK; Williams CD; Cossor FI; Kelley MJ; Martell RE
Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1418-1425. PubMed ID: 27496094
[TBL] [Abstract][Full Text] [Related]
6. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.
Lee MS; Hsu CC; Wahlqvist ML; Tsai HN; Chang YH; Huang YC
BMC Cancer; 2011 Jan; 11():20. PubMed ID: 21241523
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies.
Du L; Wang M; Kang Y; Li B; Guo M; Cheng Z; Bi C
Oncotarget; 2017 Apr; 8(16):26448-26459. PubMed ID: 28103573
[TBL] [Abstract][Full Text] [Related]
8. [The effect of metformin on responses to chemotherapy and survival in stage IV colorectal cancer with diabetes].
Lee DJ; Kim B; Lee JH; Park SJ; Hong SP; Cheon JH; Kim TI; Kim WH
Korean J Gastroenterol; 2012 Dec; 60(6):355-61. PubMed ID: 23242018
[TBL] [Abstract][Full Text] [Related]
9. [Metformin can reduce the risk of colorectal cancer].
Fransgård T; Gögenur I
Ugeskr Laeger; 2015 May; 177(21):V12140659. PubMed ID: 26027593
[TBL] [Abstract][Full Text] [Related]
10. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
Meng F; Song L; Wang W
J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
[No Abstract] [Full Text] [Related]
11. Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis.
Mei ZB; Zhang ZJ; Liu CY; Liu Y; Cui A; Liang ZL; Wang GH; Cui L
PLoS One; 2014; 9(3):e91818. PubMed ID: 24647047
[TBL] [Abstract][Full Text] [Related]
12. Metformin depresses overactivated Notch1/Hes1 signaling in colorectal cancer patients with type 2 diabetes mellitus.
Yang B; Huang CZ; Yu T; Zhou SN; Liu Q; Liu GJ; Chen S; Han FH
Anticancer Drugs; 2017 Jun; 28(5):531-539. PubMed ID: 28177944
[TBL] [Abstract][Full Text] [Related]
13. The impact of metformin on survival in diabetes patients with operable colorectal cancer: A nationwide retrospective cohort study.
Chu PT; Chuang TJ; Huang SH; Wu TH; Huang WC; Wang JH
J Int Med Res; 2023 Apr; 51(4):3000605231168033. PubMed ID: 37077173
[TBL] [Abstract][Full Text] [Related]
14. Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes.
Chen CH; Lin CL; Hsu CY; Kao CH
QJM; 2020 Mar; 113(3):194-200. PubMed ID: 31593243
[TBL] [Abstract][Full Text] [Related]
15. Effects of metformin on CD133+ colorectal cancer cells in diabetic patients.
Zhang Y; Guan M; Zheng Z; Zhang Q; Gao F; Xue Y
PLoS One; 2013; 8(11):e81264. PubMed ID: 24278407
[TBL] [Abstract][Full Text] [Related]
16. Continuous use of metformin can improve survival in type 2 diabetic patients with ovarian cancer: A retrospective study.
Wang SB; Lei KJ; Liu JP; Jia YM
Medicine (Baltimore); 2017 Jul; 96(29):e7605. PubMed ID: 28723808
[TBL] [Abstract][Full Text] [Related]
17. For colorectal cancer patients with type II diabetes, could metformin improve the survival rate? A meta-analysis.
Cheng Y; Chen Y; Zhou C; Shen L; Tu F; Xu J; Liu C
Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):73-81. PubMed ID: 31300371
[TBL] [Abstract][Full Text] [Related]
18. Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer.
Lee JH; Jeon SM; Hong SP; Cheon JH; Kim TI; Kim WH
Dig Liver Dis; 2012 Dec; 44(12):1042-7. PubMed ID: 22789400
[TBL] [Abstract][Full Text] [Related]
19. Metformin: A Salutary Candidate for Colorectal Cancer Treatment in Patients with Diabetes.
Samuel VP; Dahiya R; Singh Y; Gupta G; Sah SK; Gubbiyappa SK; Chellappan DK; Dua K
J Environ Pathol Toxicol Oncol; 2019; 38(2):133-141. PubMed ID: 31679276
[TBL] [Abstract][Full Text] [Related]
20. Effects of diabetes type 2 and metformin treatment in Swedish patients with colorectal cancer.
Dimberg J; Shamoun L; Landerholm K; Wågsäter D
World J Gastroenterol; 2022 May; 28(19):2148-2151. PubMed ID: 35664033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
